GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Resverlogix Corp (TSX:RVX) » Definitions » Forward Dividend Yield %

Resverlogix (TSX:RVX) Forward Dividend Yield % : 0.00% (As of Jun. 11, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Resverlogix Forward Dividend Yield %?

As of today (2024-06-11), the Forward Annual Dividend Yield of Resverlogix is 0.00%.

As of today (2024-06-11), the Trailing Annual Dividend Yield of Resverlogix is 0.00%.

TSX:RVX's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.65
* Ranked among companies with meaningful Forward Dividend Yield % only.

Resverlogix's Dividends per Share for the three months ended in Mar. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Resverlogix's Forward Dividend Yield %

For the Biotechnology subindustry, Resverlogix's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Resverlogix's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Resverlogix's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Resverlogix's Forward Dividend Yield % falls into.



Resverlogix Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Resverlogix  (TSX:RVX) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Resverlogix Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Resverlogix's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Resverlogix (TSX:RVX) Business Description

Traded in Other Exchanges
Address
4820 Richard Road South West, Suite 300, Calgary, AB, CAN, T3E 6L1
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Executives
Aaron Bradley Cann Senior Officer

Resverlogix (TSX:RVX) Headlines

No Headlines